Clinical Trial Update: Efficacy Safety Study of Flu Vaccine in Immunodepression Patients [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety study of an influenza vaccine in immunodepressed patients with inflammatory bowel disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• Influenza vaccine (influenza vaccine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Inflammatory Bowel Disease (IBD) | Phase 3 | Status: COMPLETED